Пропранолол

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Пропранолол

What is Propranolol?

Propranolol is the International Nonproprietary Name (INN) for a prescription medication widely used to treat various heart, circulatory, and nervous system conditions. It is classified as a non-selective beta-adrenergic blocker, commonly known as a beta-blocker. This classification means it works by blocking the effects of the stress hormone epinephrine (adrenaline) on the heart and blood vessels, thereby slowing the heart rate and relaxing blood vessels.

Property Description
Active ingredient Propranolol hydrochloride
Form Tablet (Standard & Extended-Release), Oral Solution
Pharmacological class Non-selective Beta-Adrenergic Blocker
Common use High blood pressure, Angina, Migraine prevention, Essential tremor
Rx Status Prescription Only (Rx)

Propranolol is a foundational drug supported by decades of clinical use. It is clinically recognized for its efficacy in managing conditions such as hypertension, irregular heart rhythms (arrhythmias), and chest pain (angina). Its unique ability to cross the blood-brain barrier also makes it valuable for non-cardiac uses, including reducing the physical symptoms of performance anxiety and controlling involuntary shaking associated with essential tremor.

Unlike newer, more selective beta-blockers, Propranolol's non-selective action on both beta1 and beta2 receptors allows for this broader range of therapeutic applications. It is available under various brand names, including Inderal and its extended-release forms, as well as in generic formulations. It is important to understand that Propranolol is a long-term control medication for chronic conditions and should never be stopped abruptly without consulting a healthcare provider.

What side effects are possible with Пропранолол?

Possible Side Effects and Safety Information

Propranolol's safety profile is documented by regulatory authorities, classifying adverse reactions by frequency and the physiological system affected. The most frequently documented effects (classified as common, occurring in 1 to 10 out of every 100 people) often involve the nervous and cardiovascular systems, including fatigue, cold extremities (acrocyanosis), sleep disturbances, and bradycardia (slow heart rate).

Adverse effects listed as uncommon (0.1–1%) or rare (0.01–0.1%) include gastrointestinal disturbances (nausea, diarrhea) and psychiatric effects such as hallucinations, psychoses, or mood changes, as defined in the official Summary of Product Characteristics (SmPC).

Serious Adverse Reactions and Safety Constraints

The regulatory profile identifies specific serious adverse reactions. These include the precipitation of cardiac failure, severe bradycardia or heart block, and bronchospasm, particularly in individuals with pre-existing conditions like asthma, which is a key safety constraint. The labels also document rare serious effects such as acute, reversible thrombocytopenia (low platelet count).

Specific population notes are included, such as the risk of masked hypoglycemia (low blood sugar) in patients with diabetes and increased risk of hypoglycemia in those with renal or hepatic impairment.

Furthermore, the official safety documentation specifies that abrupt cessation of the medicine can lead to a withdrawal syndrome, including the exacerbation of angina pectoris and, in rare instances, myocardial infarction. Use is officially restricted in states like uncontrolled heart failure, sick sinus syndrome, and cardiogenic shock.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Propranolol is officially documented as potentially causing severe and life-threatening clinical manifestations, primarily affecting the heart and nervous system. Official regulatory sources require immediate action for any suspected overdose.

System Documented Overdose Manifestations
Cardiovascular Bradycardia, hypotension, cardiogenic shock, syncope, QRS prolongation, ventricular arrhythmias, and asystole (cardiac arrest).
Central Nervous System Drowsiness, confusion, seizures, hallucinations, and coma in severe cases.
Other Bronchospasm, hyperkalaemia, and severe hypoglycaemia (low blood sugar), which can rarely lead to seizures or coma.

Urgent Medical Action Required

The official prescribing information mandates that if an overdose of Propranolol has been taken or is suspected, the use of the drug must be stopped, and urgent medical assistance should be sought immediately. Patients or caregivers are advised to seek emergency medical attention or contact the Poison Help line. Hospital monitoring is required to manage potential toxicity effectively.

Management procedures, as described in regulatory labels, include ensuring a clear airway, monitoring vital signs until stability is achieved, and providing specific supportive treatments like beta-2 agonist bronchodilators for bronchospasm or Glucagon for specific cardiac effects.

Population-Specific Considerations:

Regulatory documents note that the development of severe cardiovascular compromise is more likely in older patients. Additionally, hypoglycaemia is a documented risk, especially in neonates, infants, children, the elderly, or those with chronic liver disease.

Therapeutic Uses of Пропранолол

Пропранолол is applied in contexts where additional symptomatic support for symptom management is needed across various physiological systems. This medication is applied in managing conditions across several domains.


Symptomatic Support for Cardiovascular Conditions

This medication is relevant for easing symptoms related to systemic imbalance and heightened physiological activity within the cardiovascular system. It is commonly used to help with managing symptoms related to high blood pressure, irregular heartbeats, and chest pain (angina). The support provided helps ease the overall symptom burden associated with heart conditions.


Managing Neurological and High-Tension Symptoms

Пропранолол is applied across domains where short-term symptom management is appropriate for conditions characterized by episodic or fluctuating manifestations. These uses commonly include the prevention of migraine headaches, the treatment of essential tremor, and the management of symptoms related to anxiety states. It helps address symptom clusters that may become intense or disruptive, contributing to improved comfort.


Assistance with Symptoms of Heightened Systemic Burden

The medicine is considered relevant in contexts marked by increased discomfort or tension, often used when symptoms intensify and supportive relief is needed. It is applied when symptoms create noticeable physiological strain, offering symptomatic relief that helps patients cope more steadily with difficult episodes where symptoms become temporarily overwhelming.


Quick Facts: Relief for Symptoms Related to High Physiological Tension and Episodic Manifestations

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Rules for Propranolol

Regulatory documentation defines strict eligibility rules for Propranolol, primarily through a list of contraindications where use is prohibited.


Populations for Whom Use is Prohibited (Contraindicated)

Propranolol is strictly contraindicated for patients with bronchial asthma or a history of bronchospasm (including COPD). It must also not be used in individuals with severe, pre-existing cardiac conditions, including:

  • Cardiogenic shock
  • Sinus bradycardia (abnormally slow heart rate)
  • Second or Third-Degree Atrioventricular (AV) Block (unless a pacemaker is in place)
  • Uncontrolled Congestive Heart Failure

Other absolute contraindications include Metabolic Acidosis and Untreated Phaeochromocytoma.


Restricted and Conditional Use

  • Age: The medication is generally allowed for adults. The safety and efficacy of standard formulations are not established for the general pediatric population. Older adults may require caution due to potential age-related organ impairment.
  • Organ Function: Use requires caution in patients with Hepatic Impairment or Renal Impairment due to the potential for altered drug clearance, as described in official labeling.
  • Pregnancy/Lactation: Use during pregnancy is restricted and generally not recommended unless clinically necessary. Propranolol is excreted into breast milk, and use during lactation requires monitoring of the infant.
  • Comorbidities: Caution is required in patients with Diabetes Mellitus, as Propranolol may mask the signs of acute hypoglycemia, an official restriction documented by regulatory authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe several categories of medicinal products that may interact with Propranolol. These interactions are generally classified based on their mechanism: either altering the concentration of Propranolol in the body (pharmacokinetic) or causing an excessive or antagonistic effect when combined (pharmacodynamic).


Documented Interaction Categories and Constraints

Interaction Domain Mechanism and Regulatory Constraint
Metabolic Enzyme Inhibitors Co-administration with inhibitors of CYP2D6, CYP1A2, or CYP2C19 is documented to increase Propranolol plasma concentrations.
Metabolic Enzyme Inducers Co-administration with inducers of CYP1A2 and CYP2C19 is documented to decrease Propranolol plasma concentrations.
Cardiovascular Agents Non-dihydropyridine calcium channel blockers ( verapamil, diltiazem) and other agents such as digoxin may increase the risk of severe bradycardia or A-V conduction disturbances. Avoidance or extreme caution is required for these combinations.
Antihypertensives NSAIDs may antagonize the blood pressure-lowering effect of Propranolol. The withdrawal of clonidine in combined therapy must follow a specific sequence: the beta-blocker must be discontinued first and gradually over several days before clonidine withdrawal.
Anticoagulants Co-administration with warfarin requires monitoring of prothrombin time due to the potential for increased anticoagulant effects.

Additional Specific Notes

Propranolol may increase the concentration of rizatriptan and alcohol may also increase propranolol blood levels. A population-specific constraint notes that patients with a history of anaphylactic reaction may have an impaired response to epinephrine when co-administered with Propranolol.

Mechanism of Action

Пропранолол is a non-selective antagonist of beta1 and beta2 adrenergic receptors, blocking the action of endogenous catecholamines such as epinephrine and norepinephrine. The primary targets are beta1 receptors located in cardiac tissue and beta2 receptors located in bronchial and vascular smooth muscle, among other sites.

At the cellular level, the antagonism prevents the binding of catecholamines, thereby inhibiting the activation of adenylyl cyclase. This blockade subsequently reduces the intracellular production of cyclic adenosine monophosphate (cAMP) and diminishes protein kinase A (PKA)-mediated phosphorylation. The downstream consequence in the myocardium is a reduction in the influx of calcium ions into the cell.

Systemically, the suppression of beta1 receptor signaling results in decreased chronotropy (heart rate) and reduced inotropy (force of myocardial contraction). This leads to a measurable decrease in cardiac output and myocardial oxygen demand. Furthermore, antagonism of beta2 receptors can cause a measurable increase in airway resistance and vascular tone due to smooth muscle processes. These combined actions modulate the hemodynamic parameters of the cardiovascular system.

Dosage and Administration Information

How to Use Propranolol

The usage of Propranolol is defined by its approved formulations and a structured administration protocol.

Administration and Dosage

Propranolol is predominantly administered via the oral route as tablets, capsules, or oral solution. The intravenous (IV) route is reserved for use in acute situations, such as certain arrhythmias, with the instruction to administer the dose slowly, not exceeding a rate of 1 mg per minute.

Oral dosing patterns vary significantly by formulation:

Form Frequency Pattern Key Contextual Instruction
Immediate-Release (IR) Tablets Typically two to four times daily (BID to QID). IR forms for certain uses are often taken before meals and at bedtime.
Extended-Release (XL) Capsules Once daily (QD). Must be taken consistently, either always with food or always on an empty stomach.

Procedural and Population Rules

Treatment must begin with the lowest starting dose for the specific condition, followed by a period of gradual titration (dose increase) over several days to weeks until the required maintenance dose range is achieved. Discontinuation of chronic therapy should not be abrupt; instructions specify that the dose should be tapered gradually over a period of seven to fourteen days.

For specific patient groups, the standard protocols include adjustments: older adults should generally start with the lowest available dose, and pediatric dosing for certain uses is based on body weight. Extended-release capsules must be swallowed whole and must not be crushed, chewed, or opened.

Recent Clinical Evidence

Propranolol, a non-selective beta-blocker, has long been a staple in treating conditions such as hypertension, angina pectoris, cardiac arrhythmias, and for migraine prophylaxis. Recent clinical evidence and ongoing trials continue to explore its role, particularly in non-cardiovascular indications.


Expanding Therapeutic Applications

Recent research has focused on the drug's established efficacy in managing the physical symptoms of anxiety, such as tremor and tachycardia (rapid heartbeat), particularly in cases of performance or situational anxiety. While its use for generalized anxiety remains under review, it offers clear benefits for the physical manifestation of stress.

Beyond traditional uses, clinical studies are actively investigating its potential in several specialized areas:

  • Post-Traumatic Stress Disorder (PTSD): Studies are exploring propranolol's ability to interfere with the reconsolidation of traumatic memories, potentially diminishing the emotional impact of the memory when it is recalled.
  • Oncology: Early phase trials are examining propranolol's effect on certain cancers, such as triple-negative breast cancer and sarcomas, often in combination with immunotherapy agents like pembrolizumab, with the hypothesis that beta-blockade may aid in tumor re-sensitization.
  • Vascular Anomalies: Following its success in treating infantile hemangiomas, research is also targeting other rare vascular conditions like Hereditary Hemorrhagic Telangiectasia (HHT), focusing on reducing epistaxis (nosebleeds) through its anti-angiogenic properties.

Migraine and Stroke Risk

Existing high-quality evidence supports propranolol as a first-line agent for the prevention of episodic migraines. Further population-based analyses have suggested a potential benefit, specifically finding that propranolol use in women who experience migraines, particularly those without aura, is associated with a reduced risk of ischemic stroke. These findings underscore the continued relevance of this long-established medication.

Key Studies & References

  1. NICE Guideline NG136: Headaches in over 12s: diagnosis and management (Propranolol for migraine prophylaxis)

Frequently Asked Questions (FAQ)

Common questions about Пропранолол (FAQ)

Q: How is the mechanism of action for migraine prevention different from its heart-related uses?

A: According to official product information, the exact mechanism by which Propranolol helps prevent migraines has not been fully established. Regulatory studies note the presence of beta-adrenergic receptors in the pial vessels of the brain, suggesting a possible connection to its efficacy for this condition.


Q: How long does the effect of a single dose of the immediate-release tablet typically last?

A: The immediate-release form is typically described as being taken multiple times per day. Pharmacokinetic studies show that the drug's plasma half-life, the time it takes for half the medicine to be eliminated, is generally between three and six hours.


Q: How long does the drug stay in the body after the last dose?

A: The medicine's presence in the body is determined by its half-life, which is generally reported as three to six hours. The official documentation indicates that the body's clearance of the drug is primarily related to blood flow through the liver.


Q: Can the extended-release capsules be opened or split if a smaller dose is needed?

A: Official instructions state that extended-release capsules must not be crushed, chewed, or opened. This measure is required to ensure the intended slow and consistent release of the medication.


Q: Is difficulty falling asleep (insomnia) a known side effect of this medicine?

A: Official safety documentation lists sleep disturbances as a common side effect of Propranolol. In addition to this, rare reports have noted vivid dreams as an adverse reaction.


Q: What is the information on taking Propranolol with other medicines for depression or anxiety (like SSRIs)?

A: Regulatory documents indicate that certain medicines, including some antidepressants, can inhibit the metabolism of Propranolol. This action can lead to increased concentrations of the drug in the blood, which may raise the risk of experiencing adverse effects such as a slowed heart rate.


Q: What precautions should be taken regarding Propranolol if a person is going to have surgery?

A: Official warnings note a specific precaution regarding low blood sugar (hypoglycemia) in patients taking Propranolol. This risk is particularly noted in patients who are fasting, such as when preparing for a surgical procedure.


Q: Why does Propranolol sometimes get referred to as an 'anti-anxiety' medication?

A: Propranolol is officially approved for conditions like essential tremor and rapid heart rate (tachycardia) that involve physical symptoms similar to those experienced during anxiety. Research has examined its role in managing these physical manifestations of situational anxiety.


Q: Does Propranolol cross the blood-brain barrier, and what does this mean for its effects?

A: The medicine is noted for its ability to cross the blood-brain barrier. The effects on the central nervous system are reflected in the official documentation of rare psychiatric adverse effects, which can include mood changes, psychoses, or hallucinations.


Q: Does Propranolol treat the cause of the condition or just the symptoms?

A: Regulatory documentation describes Propranolol as a long-term control medication for managing chronic conditions. It works by blocking the physical effects of epinephrine, the stress hormone, thereby controlling symptoms rather than eliminating the underlying cause of the condition.


Q: Can Propranolol affect a person's mood or emotional response?

A: Official documents list mood changes, psychoses, and hallucinations as rare psychiatric adverse effects. These effects are considered uncommon and are noted in the safety documentation.


Q: What is the information on Propranolol affecting memory or concentration?

A: Rare adverse effects documented in official labeling include a slightly clouded sensorium and decreased performance on neuropsychometrics, which relates to cognitive function.


Q: Can Propranolol cause cold hands and feet?

A: The side effect of cold extremities, also known as acrocyanosis, is listed as a common effect in official safety documentation. This is generally related to the effects of the medication on circulation.


Q: Is it safe to consume alcohol while taking Propranolol?

A: Regulatory documents note that alcohol can increase the concentration of Propranolol in the blood. This combination may have an additive effect in lowering blood pressure, which can increase the risk of side effects such as dizziness or fainting.


Q: Is Propranolol use limited by age, such as for children or the elderly?

A: The official guidance indicates that the safety and efficacy of the standard formulations have not been established for the general pediatric population. For older adults, official instructions indicate that treatment should generally begin with the lowest available dose.


Q: What is the guidance for using Propranolol if a person has naturally low blood pressure?

A: The medicine is strictly contraindicated for individuals with a severely slow heart rate, known as sinus bradycardia. Because the drug can cause low blood pressure (hypotension) as a side effect, caution is noted in regulatory documents when blood pressure is already low.


Q: Can Propranolol cause heart problems to worsen in some patients?

A: Official safety documentation strictly contraindicates the drug in cases of uncontrolled Congestive Heart Failure. Furthermore, the precipitation of cardiac failure is listed as a potential serious adverse reaction in the regulatory warnings.


Q: Is Propranolol ever prescribed for essential tremor?

A: Yes, Propranolol is an FDA-approved prescription medication for the management and treatment of essential tremor, which involves involuntary shaking.


Q: Is there a risk of low blood sugar (hypoglycemia) in patients who are fasting?

A: Official warnings state that Propranolol use has been associated with low blood sugar (hypoglycemia). This risk is particularly noted in official documents when the person is fasting or has diabetes.


Q: What is the advice for someone with a history of severe allergic reactions?

A: Official documentation notes that Propranolol can lead to an impaired response to the typical doses of epinephrine in patients who have a history of a severe allergic reaction (anaphylaxis). This interaction is a specific warning noted in the regulatory labeling.

How should Пропранолол be stored and disposed of?

Storage and Protection Requirements

Official regulatory labeling dictates that Propranolol, in most solid dosage forms, must be stored at Controlled Room Temperature, defined as 20 to 25 C (68 to 77 F). The medication must be protected from light, moisture, freezing, and excessive heat to maintain product stability and integrity.

Storage Condition Requirement
Temperature 20 to 25 C (68 to 77 F)
Container Tight, light-resistant container
Prohibited Freezing and excessive heat

The product must be dispensed and kept in a tight, light-resistant container. As a mandatory safety measure, Propranolol must always be stored out of the reach of children.

Disposal Instructions

Unused, expired, or waste material must be disposed of in accordance with local requirements established by regulatory bodies. Patients should not dispose of this product via wastewater or household waste unless otherwise explicitly instructed by the labeling, typically to prevent environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Пропранолол found in:

A-Z Index: